The most frequently referenced 12-month forecast for the ADR comes in near $37.75, drawn from both Yahoo Finance and stockanalysis.com averages. Rounding that figure produces the central target of $38. Wider aggregations that incorporate converted domestic estimates show a broader spread, with lows around $34 and highs above $44 according to Barron’s and MarketWatch.
Opinions vary across firms. Bank of America Securities kept a Buy rating with a $34 target in late October 2026, while DBS lowered its Buy-rated target to $33.50 in May 2026. Other tracked estimates reach as high as $40. On the Indian shares, sentiment stays largely positive: after the latest results, 49 of 51 analysts carried buy or overweight ratings with none on sell, and major houses including Goldman Sachs, Morgan Stanley, J.P. Morgan, and Nomura lifted targets on the back of loan growth and margin visibility. I also checked this using Tickeron’s AI Screener to compare the stock with peers in the sector. No average is certain, and the clustering near $34 versus the $44 high illustrates real differences in outlook for earnings growth.
At a recent price near $34.50, IBN trades just below its 52-week high around $35 and well above the low of $25.08. Reaching $38 would require roughly a 10% advance, a modest step that still needs to clear the round-number resistance and prior-high area. Trailing P/E sits near 19.6, price-to-book around 3.1, return on equity approximately 16.5%, and the dividend yield is about 0.73%. Market capitalization for the ADR is roughly $123 billion to $125 billion.
Fundamentals provide the clearest backing. In the September 2026 quarter, ICICI Bank posted about a 20% year-over-year increase in standalone net profit to roughly ₹14,843 crore, with net interest income rising 17.7%. Loans expanded around 30% year-over-year and deposits 27%, leaving the loan-to-deposit ratio near 85% with room for further profitable growth. The Reserve Bank of India approved a two-year extension for CEO Sandeep Bakhshi through October 2028, easing succession concerns. A generally bullish consensus and India’s ongoing credit expansion story reinforce the constructive view.
Margin pressure stands out as the primary concern rather than balance-sheet issues. Net interest margin eased to about 4.18% in the latest quarter from 4.36% sequentially, and analysts note that a rise in non-resident foreign currency deposits could weigh on margins ahead. Unsecured retail lending has been softer, and valuation is no longer inexpensive after the rally—the ADR carries a premium multiple near its highs, so any earnings or macro shortfall could lead to multiple compression. A slowdown in India’s credit cycle, higher funding costs, or reduced appetite for emerging-market financials would all complicate the route to $38.
The shares are consolidating just under durable resistance near $35, the 52-week high and a psychological round number. A clear break above that zone would remove the near-term barrier on the way to $38. On the downside, the prior breakout zone around $32–$33 provides initial support, with deeper levels near $29–$30. The longer-term uptrend remains intact after the climb from the mid-$20s, yet proximity to resistance means momentum needs to hold for further progress.
Most analyst targets cover a roughly 12-month horizon. The next earnings release is expected around mid-January 2027, and commentary on margins, credit growth, and asset quality will be closely followed. Additional factors include analyst revisions, Reserve Bank of India policy moves, FCNR-B deposit flows, and trends in unsecured lending. Given that some recent ADR targets sit near or below the current price, further revisions will indicate how views are evolving after the advance.
When reviewing IBN, I occasionally reference Tickeron’s AI Daily Buy/Sell Signals to gain a data-driven layer alongside traditional research. The system applies artificial intelligence to scan thousands of stocks and ETFs, producing Buy, Sell, or Hold signals that reflect shifting conditions and technical patterns. This approach helps identify fresh opportunities and track evolving trends without replacing fundamental analysis.
The $38 central target for ICICI Bank (IBN) represents the rounded mean of estimates clustered near $37.75, with the range running from about $34 to $44. From a recent price near $34.50, the implied move is a modest 10%, backed by strong loan growth, solid profitability, leadership continuity, and broad analyst support. The main challenges remain margin compression, softer unsecured lending, premium valuation after the rally, and technical resistance at the 52-week high near $35. The wide target spread and presence of some estimates at or below current levels indicate this is not a uniform outlook. Investors should focus on the earnings path, margin trends, and revisions in the coming quarters rather than viewing $38 as assured.
I find Tickeron’s AI Daily Buy/Sell Signals useful for monitoring IBN and similar names in real time. The tool processes market data continuously to flag potential shifts, which complements my review of earnings and analyst notes. It has become a regular part of my workflow for spotting changes across a wide universe of securities.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The 10-day moving average for IBN crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 20 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 55%.
The Momentum Indicator moved above the 0 level on November 02, 2026. You may want to consider a long position or call options on IBN as a result. In 42 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 49%.
IBN moved above its 50-day moving average on October 29, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +2.92% 3-day Advance, the price is estimated to grow further. Considering data from situations where IBN advanced for three days, in 145 of 287 cases, the price rose further within the following month. The odds of a continued upward trend are 51%.
The Aroon Indicator entered an Uptrend today. In 95 of 233 cases where IBN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 41%.
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IBN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 41%.
IBN broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron SMR rating for this company is 1 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 15 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: IBN's P/B Ratio (0.032) is slightly lower than the industry average of (1.262). P/E Ratio (0.216) is within average values for comparable stocks, (13.479). Projected Growth (PEG Ratio) (0.240) is also within normal values, averaging (1.190). Dividend Yield (0.027) settles around the average of (0.036) among similar stocks. P/S Ratio (4.323) is also within normal values, averaging (3.738).
The Tickeron Profit vs. Risk Rating rating for this company is 22 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 58, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. IBN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a regional bank
Industry RegionalBanks